Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial

Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial

(2011) Kentaro Sugano et al.   JOURNAL OF GASTROENTEROLOGY

Safety of Proton Pump Inhibitor Exposure

(2010) Yu–Xiao Yang et al.   GASTROENTEROLOGY

Guidelines for the Management ofHelicobacter pyloriInfection in Japan: 2009 Revised Edition

(2010) Masahiro Asaka et al.   HELICOBACTER

Changes in the prevalence of Helicobacter pylori infection and gastrointestinal diseases in the past 17 years

(2010) Shigemi Nakajima et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Safety of the long-term use of proton pump inhibitors

(2010) Alan BR Thomson   WORLD JOURNAL OF GASTROENTEROLOGY

ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

(2008) Deepak L. Bhatt et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

(2008) Kazutoshi Fukase et al.   LANCET